Clinical Trial

Efficacy of Tetrachlorodecaoxide (TCDO) Drops in Chronic Wound Healing

Study acronym: TCDO-Wound
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 5, 2025 (before its estimated July 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center, randomized controlled trial evaluating the effectiveness of topical tetrachlorodecaoxide (TCDO) solution in enhancing chronic wound healing. The study will compare standard wound care with and without the addition of topical TCDO drops. Eligible adult participants with chronic wounds of more than six weeks' duration will be randomly assigned to either the intervention or control group. The trial aims to assess the rate of wound healing, time to 50% wound closure, pain reduction measured by the Visual Analog Scale (VAS), and cost-effectiveness.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-24.
Trial Details
NCT Number NCT07096830
Lead Sponsor Fazeelat Bibi
Conditions Chronic Wound Care
Enrollment 66 participants
Start Date 2025-08-30
Primary Completion 2026-07-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2025-08-05